Common Stock, Shares, Outstanding of NRX Pharmaceuticals, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
NRX Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 27,682,530, a 143% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

NRX Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 27,682,530 +16,309,284 +143% 30 Sep 2025 10-Q 14 Nov 2025 2024 Q3
Q2 2025 19,473,588 +8,681,958 +80% 30 Jun 2025 10-Q 18 Aug 2025 2024 Q2
Q1 2025 17,120,120 +7,347,448 +75% 31 Mar 2025 10-Q 15 May 2025 2024 Q1
Q4 2024 14,591,505 +6,199,549 +74% 31 Dec 2024 10-Q 14 Nov 2025 2024 Q3
Q3 2024 11,373,246 -72,546,308 -86% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 10,791,630 -69,596,700 -87% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 9,772,672 -60,536,983 -86% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 8,391,956 -58,051,033 -87% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 83,919,554 +16,278,240 +24% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 80,388,330 +13,747,016 +21% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 70,309,655 +3,668,341 +5.5% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 66,442,989 +7,632,439 +13% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 67,641,314 +67,641,314 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 66,641,314 +18,037,729 +37% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 66,641,314 +63,953,072 +2379% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 58,810,550 +15,837,088 +37% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 0 -2,688,242 -100% 30 Sep 2021 10-Q/A 12 Aug 2022 2021 Q3
Q2 2021 48,603,585 +45,887,557 +1690% 30 Jun 2021 10-Q/A 12 Aug 2022 2021 Q2
Q1 2021 2,688,242 -27,786 -1% 31 Mar 2021 10-Q 21 May 2021 2021 Q1
Q4 2020 42,973,462 +40,129,048 +1411% 31 Dec 2020 10-Q/A 12 Aug 2022 2021 Q3
Q3 2020 2,688,242 -122,019 -4.3% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 2,716,028 -85,322 -3% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 2,716,028 -78,269 -2.8% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 2,844,414 +119,375 +4.4% 31 Dec 2019 10-K/A 14 May 2021 2020 FY
Q3 2019 2,810,261 +172,199 +6.5% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 2,801,350 +178,766 +6.8% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 2,794,297 +188,515 +7.2% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 2,725,039 +134,054 +5.2% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 2,638,062 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 2,622,584 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 2,605,782 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 2,590,985 31 Dec 2017 10-K 15 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.